Wave Life Sciences Ltd. Y95308105 SG9999014716 08/01/2023 To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 6031000 0 FOR 6031000 FOR AMC Entertainment Holdings, Inc. 00165C302 US00165C3025 11/08/2023 Say on Pay - An advisory vote to approve the compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES 5371 0 AGAINST 5371 AGAINST Zymeworks Inc. 98985Y108 US98985Y1082 12/07/2023 Advisory Vote on the compensation of named executive officers SECTION 14A SAY-ON-PAY VOTES 64900 0 FOR 64900 FOR Standard BioTools Inc. 34385P108 US34385P1084 01/04/2024 Standard BioTools Advisory Compensation Proposal. To approve, on a non-binding, advisory basis, the compensation that may become payable to Standard BioTools' named executive officers and to SomaLogic's Chief Executive Officer that is based on or otherwise relates to the Merger, as disclosed in "The Merger - Interests of Standard BioTools Directors and Executive Officers in the Merger - Quantification of Potential Payments to Standard BioTools Named Executive Officers and SomaLogic's Chief Executive Officer in Connection with the Merger" beginning on page 127 of the accompanying joint proxy statement/prospectus (the "Standard BioTools Advisory Compensation Proposal"); SECTION 14A SAY-ON-PAY VOTES 5271 17003 FOR 5271 FOR Geospace Technologies Corporation 37364X109 US37364X1090 02/08/2024 To approve the following non-binding, advisory resolution: ''RESOLVED, that the stockholders approve the compensation of the Company's named executive officers as disclosed in the Company's 2024 proxy statement pursuant to Item 402 of Regulation S-K, (which disclosure includes the Overview of the Company Executive Compensation Program, the Summary Compensation Table and the other executive compensation tables and related discussion).'' SECTION 14A SAY-ON-PAY VOTES 18261 0 FOR 18261 FOR FingerMotion, Inc. 31788K108 US31788K1088 02/16/2024 To approve, on a non-binding advisory basis, the compensation of the named executive officers, as more particularly described in the Schedule 14A - Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 0 51393 DID NOT VOTE 0 NONE Bassett Furniture Industries, Incorporated 070203104 US0702031040 03/06/2024 PROPOSAL to consider and act on an advisory vote regarding the approval of compensation paid to certain executive officers. SECTION 14A SAY-ON-PAY VOTES 9512 0 FOR 9512 FOR DLH Holdings Corp. 23335Q100 US23335Q1004 03/14/2024 An Advisory Vote regarding the approval of compensation paid to our named Executive Officers. SECTION 14A SAY-ON-PAY VOTES 7998 0 FOR 7998 FOR Lennar Corporation 526057302 US5260573028 04/10/2024 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 138677 0 AGAINST 138677 AGAINST Rekor Systems, Inc. 759419104 US7594191048 04/18/2024 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 5998 32538 FOR 5998 FOR Franklin Financial Services Corporation 353525108 US3535251082 04/23/2024 Say on Pay - Executive Compensation SECTION 14A SAY-ON-PAY VOTES 500 0 FOR 500 FOR BorgWarner Inc. 099724106 US0997241064 04/24/2024 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1165971 134029 FOR 1165971 FOR Citigroup Inc. 172967424 US1729674242 04/30/2024 Advisory vote to Approve our 2023 Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 300000 0 FOR 300000 FOR Capital One Financial Corporation 14040H105 US14040H1059 05/02/2024 Advisory vote on our Named Executive Officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES 335000 0 FOR 335000 FOR Ryder System, Inc. 783549108 US7835491082 05/03/2024 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 194940 0 FOR 194940 FOR Carvana Co. 146869102 US1468691027 05/06/2024 Approval, by an advisory vote, of Carvana's executive compensation. SECTION 14A SAY-ON-PAY VOTES 324833 20167 FOR 324833 FOR Cogent Communications Holdings, Inc. 19239V302 US19239V3024 05/08/2024 PROPOSAL - Non-binding Advisory Vote to Approve Named Executive Officer Compensation; SECTION 14A SAY-ON-PAY VOTES 187134 7866 FOR 187134 FOR Enova International, Inc. 29357K103 US29357K1034 05/08/2024 A non-binding advisory vote to approve the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 250000 0 FOR 250000 FOR Hilton Grand Vacations Inc. 43283X105 US43283X1054 05/08/2024 Approve by non-binding vote the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1194508 5492 FOR 1194508 FOR Discover Financial Services 254709108 US2547091080 05/09/2024 Advisory vote to approve named executive officer compensation: SECTION 14A SAY-ON-PAY VOTES 20000 0 FOR 20000 FOR Zevra Therapeutics, Inc. 488445206 US4884452065 05/13/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials SECTION 14A SAY-ON-PAY VOTES 779179 20821 FOR 779179 FOR QuidelOrtho Corporation 219798105 US2197981051 05/14/2024 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. SECTION 14A SAY-ON-PAY VOTES 129919 81 FOR 129919 FOR Xenia Hotels & Resorts, Inc. 984017103 US9840171030 05/14/2024 To approve, on an advisory and non-binding basis, the compensation of the named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 1470097 4903 FOR 1470097 FOR RXO, Inc. 74982T103 US74982T1034 05/20/2024 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 448177 51823 FOR 448177 FOR Noble Corporation plc G65431127 GB00BMXNWH07 05/21/2024 Approval of the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES 73209 74983 FOR 73209 FOR Viking Therapeutics, Inc. 92686J106 US92686J1060 05/21/2024 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES 356376 3624 FOR 356376 FOR Cardlytics, Inc. 14161W105 US14161W1053 05/23/2024 Advisory vote to approve compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES 1844354 155546 AGAINST 1844354 AGAINST Apellis Pharmaceuticals, Inc. 03753U106 US03753U1060 06/05/2024 Approval of an advisory vote on executive compensation; and SECTION 14A SAY-ON-PAY VOTES 181472 33528 FOR 181472 FOR FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1660214 189786 FOR 1660214 FOR FibroGen, Inc. 31572Q808 US31572Q8087 06/05/2024 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 1660214 189786 ONE YEAR 1660214 FOR Gossamer Bio, Inc. 38341P102 US38341P1021 06/06/2024 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 3300000 0 AGAINST 3300000 AGAINST MeiraGTx Holdings Plc G59665102 KYG596651029 06/06/2024 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2474865 25135 FOR 2474865 FOR MeiraGTx Holdings Plc G59665102 KYG596651029 06/06/2024 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2474865 25135 ONE YEAR 2474865 AGAINST Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 advisory vote to approve, on a non-binding basis, name executive officer compensation SECTION 14A SAY-ON-PAY VOTES 60479 2350 FOR 60479 FOR SAGE Therapeutics, Inc. 78667J108 US78667J1088 06/10/2024 To hold a non-binding advisory vote to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 205976 69024 FOR 205976 FOR Aadi Bioscience, Inc. 00032Q104 US00032Q1040 06/11/2024 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES 200000 0 FOR 200000 FOR Caesars Entertainment, Inc. 12769G100 US12769G1004 06/11/2024 COMPANY PROPOSAL: ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES 269560 75440 FOR 269560 FOR Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/11/2024 To approve, by non-binding advisory vote, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES 737178 487822 FOR 737178 FOR LendingClub Corporation 52603A208 US52603A2087 06/11/2024 Approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 201400 0 FOR 201400 FOR Valaris Limited G9460G101 BMG9460G1015 06/12/2024 To approve on a non-binding advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 133511 59646 FOR 133511 FOR Western Alliance Bancorporation 957638109 US9576381092 06/12/2024 Approve, on a non-binding advisory basis, executive compensation (say on pay). SECTION 14A SAY-ON-PAY VOTES 200000 0 FOR 200000 FOR Western Alliance Bancorporation 957638109 US9576381092 06/12/2024 Approve, on a non-binding advisory basis, frequency of the non-binding vote on executive compensation (say on frequency). SECTION 14A SAY-ON-PAY VOTES 200000 0 ONE YEAR 200000 FOR Etsy, Inc. 29786A106 US29786A1060 06/13/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 110000 0 AGAINST 110000 AGAINST Ponce Financial Group, Inc. 732344106 US7323441060 06/13/2024 Approval, on an advisory and non-binding basis, of the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES 94877 11260 AGAINST 94877 AGAINST Tesla, Inc. 88160R101 US88160R1014 06/13/2024 A Tesla proposal to approve executive compensation on a non-binding advisory basis. SECTION 14A SAY-ON-PAY VOTES 46500 0 FOR 46500 FOR Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/14/2024 Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES 585000 0 AGAINST 585000 AGAINST TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/14/2024 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 785658 593496 AGAINST 785658 AGAINST uniQure N.V. N90064101 NL0010696654 06/18/2024 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES 1975000 0 FOR 1975000 FOR Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/20/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 700000 0 FOR 700000 FOR BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/21/2024 To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 101328 18672 FOR 101328 FOR